Microglial cells: the main HIV-1 reservoir in the brain
C Wallet, M De Rovere, J Van Assche… - Frontiers in cellular …, 2019 - frontiersin.org
Despite efficient combination of the antiretroviral therapy (cART), which significantly
decreased mortality and morbidity of HIV-1 infection, a definitive HIV cure has not been …
decreased mortality and morbidity of HIV-1 infection, a definitive HIV cure has not been …
HIV-associated neurocognitive disorder
DB Clifford, BM Ances - The Lancet infectious diseases, 2013 - thelancet.com
Neurological involvement in HIV is often associated with cognitive impairment. Although
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era …
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era …
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
Objective To test the hypothesis that coronavirus disease 2019 (COVID-19) has an impact
on the CNS by measuring plasma biomarkers of CNS injury. Methods We recruited 47 …
on the CNS by measuring plasma biomarkers of CNS injury. Methods We recruited 47 …
Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis
MR Wilson, HA Sample, KC Zorn… - … England Journal of …, 2019 - Mass Medical Soc
Background Metagenomic next-generation sequencing (NGS) of cerebrospinal fluid (CSF)
has the potential to identify a broad range of pathogens in a single test. Methods In a 1-year …
has the potential to identify a broad range of pathogens in a single test. Methods In a 1-year …
Controversies in HIV-associated neurocognitive disorders
S Nightingale, A Winston, S Letendre… - The Lancet …, 2014 - thelancet.com
Cross-sectional studies show that around half of individuals infected with HIV-1 have some
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
MJ Peluso, F Ferretti, J Peterson, E Lee, D Fuchs… - Aids, 2012 - journals.lww.com
Objective: To characterize HIV-infected patients with neurosymptomatic cerebrospinal fluid
(CSF)'escape', defined as detectable CSF HIV RNA in the setting of treatment-suppressed …
(CSF)'escape', defined as detectable CSF HIV RNA in the setting of treatment-suppressed …
Cognitive impairment in people living with HIV in the ART era: a review
K Alford, JH Vera - British medical bulletin, 2018 - academic.oup.com
Background Cognitive disorders are a common issue impacting those living with human
immunodeficiency virus (HIV). Effective antiretroviral treatment has lessened the severity but …
immunodeficiency virus (HIV). Effective antiretroviral treatment has lessened the severity but …
Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)
Z Zayyad, S Spudich - Current Hiv/Aids Reports, 2015 - Springer
Early in the HIV epidemic, the central nervous system (CNS) was recognized as a target of
infection and injury in the advanced stages of disease. Though the most severe forms of HIV …
infection and injury in the advanced stages of disease. Though the most severe forms of HIV …
HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment
S Spudich, F González-Scarano - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
HIV-associated central nervous system (CNS) injury continues to be clinically significant in
the modern era of HIV infection and therapy. A substantial proportion of patients with …
the modern era of HIV infection and therapy. A substantial proportion of patients with …
Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance
S Spudich, KR Robertson, RJ Bosch… - The Journal of …, 2019 - Am Soc Clin Investig
BACKGROUND Persistence of HIV in sanctuary sites despite antiretroviral therapy (ART)
presents a barrier to HIV remission and may affect neurocognitive function. We assessed …
presents a barrier to HIV remission and may affect neurocognitive function. We assessed …